We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3D Systems (DDD), Enhatch Boost Personalized Medical Delivery
Read MoreHide Full Article
3D Systems (DDD - Free Report) announced that it has inked a partnership with the Hoboken-based Intelligent Surgery Ecosystem developer — Enhatch — to jointly design and deliver patient-specific medical devices.
Founded in 2012, Enhatch develops software applications powered by artificial intelligence to streamline surgical elements. Utilizing advanced analytics, it evaluates and mitigates potential risks in the surgical planning process. Its data-driven technology aids surgeons and medical device companies to spend less time on surgical plannings and more time on their patients.
Enhatch’s Intelligent Surgery Ecosystem is an end-to-end technology platform delivering intelligent surgery solutions, which elevate patient care to new heights. Incorporating Enhatch's advanced technologies into its medical device workflow for developing patient-specific solutions, 3D Systems will be able to meet the growing demand for personalized medical devices more efficiently.
This alliance will help 3D Systems generate an optimized, automated and scalable workflow making surgical processes trackable and cost-efficient.
3D Systems is currently witnessing robust prospects across most of its end business. DDD remains bullish on the prospects of its healthcare business. The consistent demand for printers and materials for medical and dental customers is fueling this segment’s growth.
The company is focusing on strategic initiatives like improving existing 3D printers, strengthening partnerships and enhancing productivity to drive growth. In February, it teamed up with Saremco Dental AG to accelerate innovation in digital dentistry. This strategic partnership intends to combine the power of 3D Systems’ NextDent digital dentistry solution with Saremco’s materials science expertise, enabling dental laboratories and clinics to address a variety of indications with unparalleled accuracy, productivity and lower costs.
Zacks Rank & Key Picks
3D Systems currently carries a Zacks Rank #4 (Sell). Shares of DDD have plunged 39.8% in the past year.
The Zacks Consensus Estimate for Advanced Micro Devices’ first-quarter fiscal 2022 earnings has been revised upward by 23 cents to 91 cents per share over the past 60 days. For fiscal 2022, Advanced Micro Devices’ earnings estimates have moved south by a penny to $3.99 per share in the past 30 days.
AMD’s earnings beat the Zacks Consensus Estimate in the preceding four quarters, the average surprise being 17%. Shares of Advanced Micro Devices have surged 58.1% in the past year.
The Zacks Consensus Estimate for Axcelis’ first-quarter 2022 earnings has been revised by 5 cents upward to 92 cents per share over the past 60 days. For 2022, Axcelis’ earnings estimates have moved north by 12.4% to $3.99 per share in the past 60 days.
Axcelis’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 30.3%. Shares of ACLS have soared 122.6% in the past year.
The Zacks Consensus Estimate for Analog Devices’ second-quarter fiscal 2022 earnings has been revised upward by 23 cents to $2.08 per share over the past 60 days. For fiscal 2022, earnings estimates have moved north by 79 cents to $8.32 per share in the past 60 days.
Analog Devices’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 6%. Shares of ADI have increased 10% in the past year.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
3D Systems (DDD), Enhatch Boost Personalized Medical Delivery
3D Systems (DDD - Free Report) announced that it has inked a partnership with the Hoboken-based Intelligent Surgery Ecosystem developer — Enhatch — to jointly design and deliver patient-specific medical devices.
Founded in 2012, Enhatch develops software applications powered by artificial intelligence to streamline surgical elements. Utilizing advanced analytics, it evaluates and mitigates potential risks in the surgical planning process. Its data-driven technology aids surgeons and medical device companies to spend less time on surgical plannings and more time on their patients.
Enhatch’s Intelligent Surgery Ecosystem is an end-to-end technology platform delivering intelligent surgery solutions, which elevate patient care to new heights. Incorporating Enhatch's advanced technologies into its medical device workflow for developing patient-specific solutions, 3D Systems will be able to meet the growing demand for personalized medical devices more efficiently.
This alliance will help 3D Systems generate an optimized, automated and scalable workflow making surgical processes trackable and cost-efficient.
3D Systems Corporation Price and Consensus
3D Systems Corporation price-consensus-chart | 3D Systems Corporation Quote
3D Systems is currently witnessing robust prospects across most of its end business. DDD remains bullish on the prospects of its healthcare business. The consistent demand for printers and materials for medical and dental customers is fueling this segment’s growth.
The company is focusing on strategic initiatives like improving existing 3D printers, strengthening partnerships and enhancing productivity to drive growth. In February, it teamed up with Saremco Dental AG to accelerate innovation in digital dentistry. This strategic partnership intends to combine the power of 3D Systems’ NextDent digital dentistry solution with Saremco’s materials science expertise, enabling dental laboratories and clinics to address a variety of indications with unparalleled accuracy, productivity and lower costs.
Zacks Rank & Key Picks
3D Systems currently carries a Zacks Rank #4 (Sell). Shares of DDD have plunged 39.8% in the past year.
Some better-ranked stocks from the broader computer and technology sector are Advanced Micro Devices (AMD - Free Report) , sporting a Zacks Rank #1 (Strong Buy), and Axcelis Technologies (ACLS - Free Report) and Analog Devices (ADI - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Advanced Micro Devices’ first-quarter fiscal 2022 earnings has been revised upward by 23 cents to 91 cents per share over the past 60 days. For fiscal 2022, Advanced Micro Devices’ earnings estimates have moved south by a penny to $3.99 per share in the past 30 days.
AMD’s earnings beat the Zacks Consensus Estimate in the preceding four quarters, the average surprise being 17%. Shares of Advanced Micro Devices have surged 58.1% in the past year.
The Zacks Consensus Estimate for Axcelis’ first-quarter 2022 earnings has been revised by 5 cents upward to 92 cents per share over the past 60 days. For 2022, Axcelis’ earnings estimates have moved north by 12.4% to $3.99 per share in the past 60 days.
Axcelis’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 30.3%. Shares of ACLS have soared 122.6% in the past year.
The Zacks Consensus Estimate for Analog Devices’ second-quarter fiscal 2022 earnings has been revised upward by 23 cents to $2.08 per share over the past 60 days. For fiscal 2022, earnings estimates have moved north by 79 cents to $8.32 per share in the past 60 days.
Analog Devices’ earnings beat the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 6%. Shares of ADI have increased 10% in the past year.